Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
about
Adoptive T cell therapy for cancer in the clinicDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationModern approaches to HLA-haploidentical blood or marrow transplantationEffects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML PatientsChimeric antigen receptor therapy for cancerIdiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosisHaploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyPrevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.Pathogenesis and management of graft-versus-host disease.The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomesKinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host diseasePredominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation.Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.Antibody- and aptamer-strategies for GvHD prevention.T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesEngineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networPhenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationOutcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.Pathophysiology of acute graft-versus-host disease: recent advances.IFNγR signaling mediates alloreactive T-cell trafficking and GVHDFactors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantationT cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinGraft-versus-host disease after donor leukocyte infusions: presentation and management.Haploidentical transplantation for hematologic malignancies: where do we stand?T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.Post-transplant adoptive T-cell immunotherapy.Pathophysiology of GvHD and Other HSCT-Related Major Complications.Epigenetic therapy in allogeneic hematopoietic stem cell transplantation.Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease.NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.Hepatic and portal vein-thrombosis.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.
P2860
Q24680405-78BEDF91-8B7B-4AD6-B114-51B0289C3166Q26767440-49BA88FB-AB8C-4F70-8FE7-09B735872F62Q26797506-C4C4B8FF-8EE8-4AC1-828D-E065ED72AF0FQ26799602-02E1B49A-7EAA-453D-A289-871BDAD1A6D7Q27013599-18A7DF6E-6C08-4861-9089-150E3EBF3EE8Q27486642-D59BF417-34C5-41D9-9158-B9E0C39C9B57Q28085397-16DF5B29-F522-4C6E-99DA-096EFC538709Q33937966-8EECFA53-D570-4066-8D76-2107F49B2868Q33997187-75247A14-DF9C-4E3D-B64F-A3CBC26FA382Q34077479-8C86A164-AF11-465C-ACDA-66922DC4B965Q34187249-29054C6C-5B49-4C14-9CF3-8B2266410ED5Q34408137-27303DD1-D594-4DCB-BECA-DC5382C790E7Q34561345-9844F34E-CBC0-4946-AE46-40D636CFD178Q34769815-69B45B89-02FC-4314-8FE7-8DAE114E97EAQ34885269-EC1B8FC9-5318-4118-9E55-4161AB47E571Q34981585-FB4FCE51-E561-4768-9EE5-1DB7001D6445Q35094029-316D96BE-F438-408E-9C66-BB9C3C94F4C6Q35148420-ADF47411-DFBD-4BA2-81E6-EBE189F0F7D6Q35587741-B44AA660-F73B-4F77-91F7-723C508432F0Q35823208-0C187CE2-D723-4773-9C25-6ECE10768576Q35849338-EBCBA48A-93BB-4AD7-A217-9D3F33D6773EQ36040293-38465325-3AAC-4DF9-8DC4-07EF53637C20Q36156559-09603C7C-C05C-4172-9211-D767A01352EBQ36395621-6183B3AD-7634-457D-90B0-083243513D54Q36418533-B4183E7D-604F-4448-829C-77848A545FECQ36447884-0B98BA7D-B036-4008-BCC9-6E4E7FB568E2Q36825001-7CFBE16C-20AB-4CDB-A2A8-53026B6CC1A4Q36854831-64ADA722-DA54-435A-A048-EB110077C390Q37014964-E8F66D18-DBC1-46B0-B9C1-AA33BB0BB20FQ37078261-D9B04723-278D-4C42-A06B-031078EC65B3Q37078916-E91CF8AC-CF1B-41CB-8177-E828DE2374D9Q37268318-5DD7A159-B4A0-4D44-AF28-3A32D069A756Q37710572-D44118B5-A355-4D92-A881-2301667FFB3EQ38112417-D6ABCD24-D195-41A4-913C-D32D9E3D111AQ41643992-B72BFB48-3015-4885-9BCE-FC2033F9B1DEQ42253060-28C51B03-9C13-4C4D-B71D-DD6EB5F9E8A4Q43165904-97D34C0D-0157-47D3-8F22-E21729667FCAQ55045366-1A938633-C374-40FE-893E-202EE985C691
P2860
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@en
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@nl
type
label
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@en
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@nl
prefLabel
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@en
Clonable T lymphocytes in T ce ...... pment of graft-v-host disease.
@nl
P2093
P1433
P1476
Clonable T lymphocytes in T ce ...... opment of graft-v-host disease
@en
P2093
P304
P407
P577
1986-09-01T00:00:00Z